Moors & Cabot Inc. purchased a new stake in Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 28,117 shares of the company’s stock, valued at approximately $1,708,000.
Several other large investors have also modified their holdings of VMRK. VestGen Advisors LLC increased its position in shares of Vivmark Residential Common Shares of Beneficial Interest by 4.7% during the 3rd quarter. VestGen Advisors LLC now owns 5,048 shares of the company’s stock worth $307,000 after purchasing an additional 225 shares during the last quarter. Planning Strategies Inc. raised its holdings in Vivmark Residential Common Shares of Beneficial Interest by 87.5% in the 3rd quarter. Planning Strategies Inc. now owns 538 shares of the company’s stock valued at $33,000 after buying an additional 251 shares during the period. Bingham Private Wealth LLC raised its holdings in Vivmark Residential Common Shares of Beneficial Interest by 7.8% in the 3rd quarter. Bingham Private Wealth LLC now owns 4,683 shares of the company’s stock valued at $285,000 after buying an additional 340 shares during the period. Blume Capital Management Inc. purchased a new stake in Vivmark Residential Common Shares of Beneficial Interest in the 3rd quarter valued at about $25,000. Finally, Rosenberg Matthew Hamilton lifted its position in Vivmark Residential Common Shares of Beneficial Interest by 47.8% in the third quarter. Rosenberg Matthew Hamilton now owns 1,301 shares of the company’s stock valued at $79,000 after buying an additional 421 shares during the last quarter. Institutional investors and hedge funds own 92.68% of the company’s stock.
Vivmark Residential Common Shares of Beneficial Interest Stock Up 0.1%
Shares of VMRK stock opened at $64.28 on Monday. The company has a debt-to-equity ratio of 0.08, a current ratio of 0.58 and a quick ratio of 0.58. Vivmark Residential Common Shares of Beneficial Interest has a 52 week low of $57.57 and a 52 week high of $71.50. The stock has a market cap of $49.80 billion, a PE ratio of 238.08, a PEG ratio of 3.43 and a beta of 0.72. The firm has a 50 day simple moving average of $62.57.
Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK – Get Free Report) last posted its quarterly earnings results on Wednesday, July 22nd. The company reported $0.30 EPS for the quarter. Vivmark Residential Common Shares of Beneficial Interest had a negative net margin of 4.21% and a negative return on equity of 0.80%. The business had revenue of $785.05 million during the quarter. Analysts expect that Vivmark Residential Common Shares of Beneficial Interest will post 4.08 EPS for the current fiscal year.
Vivmark Residential Common Shares of Beneficial Interest Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 16th. Stockholders of record on Monday, October 5th were paid a $0.7025 dividend. This represents a $2.81 annualized dividend and a dividend yield of 4.4%. The ex-dividend date was Monday, October 5th. Vivmark Residential Common Shares of Beneficial Interest’s dividend payout ratio (DPR) is presently 1,040.74%.
Analyst Ratings Changes
VMRK has been the topic of a number of recent analyst reports. Piper Sandler decreased their target price on shares of Vivmark Residential Common Shares of Beneficial Interest from $76.00 to $67.00 and set a “neutral” rating on the stock in a research report on Monday, October 12th. Cantor Fitzgerald dropped their price target on shares of Vivmark Residential Common Shares of Beneficial Interest from $70.00 to $68.00 and set a “neutral” rating for the company in a research report on Monday, November 9th. Weiss Ratings cut shares of Vivmark Residential Common Shares of Beneficial Interest from a “hold (c)” rating to a “sell (d)” rating in a research report on Tuesday, November 10th. Scotiabank reduced their price target on shares of Vivmark Residential Common Shares of Beneficial Interest from $70.00 to $66.00 and set a “sector perform” rating on the stock in a research note on Thursday, September 17th. Finally, Morgan Stanley began coverage on shares of Vivmark Residential Common Shares of Beneficial Interest in a research note on Tuesday, August 25th. They issued an “overweight” rating and a $75.00 price target on the stock. Five investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $71.42.
Check Out Our Latest Research Report on Vivmark Residential Common Shares of Beneficial Interest
Insider Transactions at Vivmark Residential Common Shares of Beneficial Interest
In related news, Director Charles E. Mueller, Jr. sold 8,000 shares of Vivmark Residential Common Shares of Beneficial Interest stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $63.90, for a total value of $511,200.00. Following the completion of the transaction, the director directly owned 16,084 shares in the company, valued at approximately $1,027,767.60. This trade represents a 33.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Chris Carr sold 1,130 shares of the business’s stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $65.28, for a total value of $73,766.40. Following the transaction, the director directly owned 4,461 shares of the company’s stock, valued at $291,214.08. The trade was a 20.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 50,461 shares of company stock valued at $3,232,596 in the last 90 days. Insiders own 1.20% of the company’s stock.
Vivmark Residential Common Shares of Beneficial Interest Profile
Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.
See Also
- Five stocks we like better than Vivmark Residential Common Shares of Beneficial Interest
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding VMRK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK – Free Report).
Receive News & Ratings for Vivmark Residential Common Shares of Beneficial Interest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivmark Residential Common Shares of Beneficial Interest and related companies with MarketBeat.com's FREE daily email newsletter.
